Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern

Variants are globally emerging very quickly following pandemic prototypic SARS-CoV-2. To evaluate the cross-protection of prototypic SARS-CoV-2 vaccine against its variants, we vaccinated rhesus monkeys with three doses of prototypic SARS-CoV-2 inactivated vaccine, followed by challenging with emerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Tianhong, Lu, Shuaiyao, He, Zhanlong, Liu, Hongqi, Wang, Junbin, Tang, Cong, Yang, Ting, Yu, Wenhai, Li, Hua, Yang, Yun, Yang, Hao, Yue, Lei, Zhou, Yanan, Yang, Fengmei, Luo, Zhiwu, Li, Yanyan, Xiang, Hong, Zhao, Yuan, Wang, Jie, Wang, Haixuan, Long, Runxiang, Kuang, Dexuan, Tan, Wenjie, Peng, Xiaozhong, Li, Qihan, Xie, Zhongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873345/
https://www.ncbi.nlm.nih.gov/pubmed/35217639
http://dx.doi.org/10.1038/s41392-022-00920-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873345/
https://www.ncbi.nlm.nih.gov/pubmed/35217639
http://dx.doi.org/10.1038/s41392-022-00920-4

Ejemplares similares